Clinical trial
A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing…
NCT00451906 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00451906 |
|---|---|
| Title | A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer. |
| Official title | Open-label Study of Bevacizumab (AVASTIN®) in Combination With Platinum-containing Chemotherapy as First-line Treatment of Patients With Advanced or Recurrent Non-squamous Non-small Cell Lung Cancer |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Non-Squamous Non-Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Platinum-based chemotherapy, Bevacizumab [Avastin] |
| Enrollment | 2,252 |
| Start date | Aug 1, 2006 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Mar 26, 2007 |
| Last update posted | May 24, 2016 |
| Countries | Argentina, Australia, Austria, Bosnia and Herzegovina, Brazil, Canada, China, Colombia, Czechia, Denmark, Ecuador, Egypt and 28 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: